Can zapping bone tumors keep breast cancer at bay?
NCT ID NCT00929214
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase 2 trial is testing whether adding local treatments like surgery or high-dose radiation to standard chemotherapy or hormone therapy can help breast cancer patients whose disease has spread to 1–3 bones. The goal is to see if this combination keeps the cancer from progressing longer than standard therapy alone. The study enrolled 35 participants and is no longer recruiting.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Standard therapy (chemotherapy and/or endocrine therapy) plus local therapy (radiation and/or surgery)
What this could lead to
If it works, this could show that aggressively treating a few bone spots helps keep breast cancer from spreading further, potentially improving how long the disease stays controlled.
What could go wrong
This is a small, early-phase trial with only 35 participants, so results may not apply to everyone. Adding local therapy also carries risks like side effects from radiation or surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States